Ionis Pharmaceuticals is a biopharmaceutical company that discovers and develops RNA-targeted therapeutics in the US. Its products include treatments for spinal muscular atrophy (SMA), polyneuropathy, familial lipodystrophy and familial chylomicronemia syndrome. Additionally, the company develops medicines for diseases such as metabolic diseases, infectious diseases, ophthalmic diseases, cancer, and renal diseases.